Headlines
•OpenAI IPO influence on AI stocks — Nvidia faces uncertainty as AI build-out pace questioned
•Greg Abel sells Bank of America for 7th consecutive quarter — Berkshire reduces BAC position
•Nvidia invested $2 billion in Nebius — Nebius stock up 57% since investment
•XRP bettors show strongest conviction for reclaiming $1.60 in May — Polymarket odds favor $1.6 over drop below $1.2
•Anthropic CEO reports 80-fold revenue and usage surge in Q1 2026 — demand for Claude products outpacing company capacity
•Claude AI flags Denali Therapeutics earnings bet — targeting upside from rare-disease drug launch
•Castle Biosciences targets $345M-$355M 2026 revenue as TissueCypher volumes grow 58% and AdvanceAD-Tx reaches ~650 orders (NASDAQ:CSTL)